Bloomberg: East Africa Seeks Streamlined Drug Oversight to Ease Access
“One of the world’s poorest regions is making itself more friendly to new products from Novartis AG, Roche Holding AG, and other drugmakers by combining the pharmacy regulators of six countries. The East African Community Medicines Registration Harmonization program allows Bayer AG, Merck KGaA, and rivals to speed products to market, while easing patients’ access to new medicines. Drugmakers would like to see the scope of the project, which started in 2012, widened to more countries…” (Anguyo, 8/30).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.